An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
Mainak BardhanDebankur DeyVinay SureshBinish JavedVyshak Alva VenurNeha JoeRitvika KalidindiAhmad OzairMarium KhanReshma MahtaniSimon LoYazmin OdiaManmeet S AhluwaliaPublished in: Expert review of neurotherapeutics (2023)
Challenges in treating NM include debates over clinical trial end points and the management of adverse effects. Drug resistance and low response rates are significant hurdles, particularly inHER2-negative breast cancer. The development of more precise and cost-effective medications with improved selectivity is crucial. Additionally, global efforts are needed for infrastructure development and cancer control considering the diverse nature of the disease.